Global Benign Prostatic Hyperplasia Devices Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Benign Prostatic Hyperplasia Devices market size was valued at USD 392 million in 2023 and is forecast to a readjusted size of USD 513.5 million by 2030 with a CAGR of 3.9% during review period.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The Global Info Research report includes an overview of the development of the Benign Prostatic Hyperplasia Devices industry chain, the market status of Hospitals and Clinics (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), Ambulatory Surgical Centers(ASC) (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Benign Prostatic Hyperplasia Devices.
Regionally, the report analyzes the Benign Prostatic Hyperplasia Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Benign Prostatic Hyperplasia Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Benign Prostatic Hyperplasia Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Benign Prostatic Hyperplasia Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Benign Prostatic Hyperplasia Devices market.
Regional Analysis: The report involves examining the Benign Prostatic Hyperplasia Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Benign Prostatic Hyperplasia Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Benign Prostatic Hyperplasia Devices:
Company Analysis: Report covers individual Benign Prostatic Hyperplasia Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Benign Prostatic Hyperplasia Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Ambulatory Surgical Centers(ASC)).
Technology Analysis: Report covers specific technologies relevant to Benign Prostatic Hyperplasia Devices. It assesses the current state, advancements, and potential future developments in Benign Prostatic Hyperplasia Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Benign Prostatic Hyperplasia Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Benign Prostatic Hyperplasia Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Benign Prostatic Hyperplasia Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Benign Prostatic Hyperplasia Devices, with price, sales, revenue and global market share of Benign Prostatic Hyperplasia Devices from 2019 to 2024.
Chapter 3, the Benign Prostatic Hyperplasia Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benign Prostatic Hyperplasia Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Benign Prostatic Hyperplasia Devices.
Chapter 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, customers, research findings and conclusion.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
The Global Info Research report includes an overview of the development of the Benign Prostatic Hyperplasia Devices industry chain, the market status of Hospitals and Clinics (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), Ambulatory Surgical Centers(ASC) (Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Benign Prostatic Hyperplasia Devices.
Regionally, the report analyzes the Benign Prostatic Hyperplasia Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Benign Prostatic Hyperplasia Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Benign Prostatic Hyperplasia Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Benign Prostatic Hyperplasia Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Transurethral Resection of the Prostate (TURP), Transurethral Microwave Therapy (TUMT)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Benign Prostatic Hyperplasia Devices market.
Regional Analysis: The report involves examining the Benign Prostatic Hyperplasia Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Benign Prostatic Hyperplasia Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Benign Prostatic Hyperplasia Devices:
Company Analysis: Report covers individual Benign Prostatic Hyperplasia Devices manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Benign Prostatic Hyperplasia Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Ambulatory Surgical Centers(ASC)).
Technology Analysis: Report covers specific technologies relevant to Benign Prostatic Hyperplasia Devices. It assesses the current state, advancements, and potential future developments in Benign Prostatic Hyperplasia Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Benign Prostatic Hyperplasia Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Benign Prostatic Hyperplasia Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Transurethral Resection of the Prostate (TURP)
- Transurethral Microwave Therapy (TUMT)
- Transurethral Needle Ablation of the Prostate (TUNA)
- Laser Surgery
- Prostatic Stenting
- Others
- Hospitals and Clinics
- Ambulatory Surgical Centers(ASC)
- Home
- Others
- Lumenis
- Olympus corporation
- Urologix
- Boston Scientific corporation
- Lisa Laser
- Medifocus
- Neotrac
- ProArc Medical LTD
- Urotech GMBH
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Benign Prostatic Hyperplasia Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Benign Prostatic Hyperplasia Devices, with price, sales, revenue and global market share of Benign Prostatic Hyperplasia Devices from 2019 to 2024.
Chapter 3, the Benign Prostatic Hyperplasia Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Benign Prostatic Hyperplasia Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Benign Prostatic Hyperplasia Devices market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Benign Prostatic Hyperplasia Devices.
Chapter 14 and 15, to describe Benign Prostatic Hyperplasia Devices sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Transurethral Resection of the Prostate (TURP)
1.3.3 Transurethral Microwave Therapy (TUMT)
1.3.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.3.5 Laser Surgery
1.3.6 Prostatic Stenting
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Ambulatory Surgical Centers(ASC)
1.4.4 Home
1.4.5 Others
1.5 Global Benign Prostatic Hyperplasia Devices Market Size & Forecast
1.5.1 Global Benign Prostatic Hyperplasia Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Benign Prostatic Hyperplasia Devices Sales Quantity (2019-2030)
1.5.3 Global Benign Prostatic Hyperplasia Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Lumenis
2.1.1 Lumenis Details
2.1.2 Lumenis Major Business
2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Product and Services
2.1.4 Lumenis Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lumenis Recent Developments/Updates
2.2 Olympus corporation
2.2.1 Olympus corporation Details
2.2.2 Olympus corporation Major Business
2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Product and Services
2.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Olympus corporation Recent Developments/Updates
2.3 Urologix
2.3.1 Urologix Details
2.3.2 Urologix Major Business
2.3.3 Urologix Benign Prostatic Hyperplasia Devices Product and Services
2.3.4 Urologix Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Urologix Recent Developments/Updates
2.4 Boston Scientific corporation
2.4.1 Boston Scientific corporation Details
2.4.2 Boston Scientific corporation Major Business
2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product and Services
2.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Boston Scientific corporation Recent Developments/Updates
2.5 Lisa Laser
2.5.1 Lisa Laser Details
2.5.2 Lisa Laser Major Business
2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Product and Services
2.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lisa Laser Recent Developments/Updates
2.6 Medifocus
2.6.1 Medifocus Details
2.6.2 Medifocus Major Business
2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Product and Services
2.6.4 Medifocus Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Medifocus Recent Developments/Updates
2.7 Neotrac
2.7.1 Neotrac Details
2.7.2 Neotrac Major Business
2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Product and Services
2.7.4 Neotrac Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Neotrac Recent Developments/Updates
2.8 ProArc Medical LTD
2.8.1 ProArc Medical LTD Details
2.8.2 ProArc Medical LTD Major Business
2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product and Services
2.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ProArc Medical LTD Recent Developments/Updates
2.9 Urotech GMBH
2.9.1 Urotech GMBH Details
2.9.2 Urotech GMBH Major Business
2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Product and Services
2.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Urotech GMBH Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BENIGN PROSTATIC HYPERPLASIA DEVICES BY MANUFACTURER
3.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2019-2024)
3.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Benign Prostatic Hyperplasia Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
3.5 Benign Prostatic Hyperplasia Devices Market: Overall Company Footprint Analysis
3.5.1 Benign Prostatic Hyperplasia Devices Market: Region Footprint
3.5.2 Benign Prostatic Hyperplasia Devices Market: Company Product Type Footprint
3.5.3 Benign Prostatic Hyperplasia Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
4.1.3 Global Benign Prostatic Hyperplasia Devices Average Price by Region (2019-2030)
4.2 North America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.3 Europe Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.5 South America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
5.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2019-2030)
5.3 Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
6.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2019-2030)
6.3 Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
7.2 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
7.3 North America Benign Prostatic Hyperplasia Devices Market Size by Country
7.3.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
8.2 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
8.3 Europe Benign Prostatic Hyperplasia Devices Market Size by Country
8.3.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Size by Region
9.3.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
10.2 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
10.3 South America Benign Prostatic Hyperplasia Devices Market Size by Country
10.3.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Market Size by Country
11.3.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Benign Prostatic Hyperplasia Devices Market Drivers
12.2 Benign Prostatic Hyperplasia Devices Market Restraints
12.3 Benign Prostatic Hyperplasia Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Benign Prostatic Hyperplasia Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Benign Prostatic Hyperplasia Devices
13.3 Benign Prostatic Hyperplasia Devices Production Process
13.4 Benign Prostatic Hyperplasia Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Benign Prostatic Hyperplasia Devices Typical Distributors
14.3 Benign Prostatic Hyperplasia Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Transurethral Resection of the Prostate (TURP)
1.3.3 Transurethral Microwave Therapy (TUMT)
1.3.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.3.5 Laser Surgery
1.3.6 Prostatic Stenting
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Benign Prostatic Hyperplasia Devices Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Ambulatory Surgical Centers(ASC)
1.4.4 Home
1.4.5 Others
1.5 Global Benign Prostatic Hyperplasia Devices Market Size & Forecast
1.5.1 Global Benign Prostatic Hyperplasia Devices Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Benign Prostatic Hyperplasia Devices Sales Quantity (2019-2030)
1.5.3 Global Benign Prostatic Hyperplasia Devices Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Lumenis
2.1.1 Lumenis Details
2.1.2 Lumenis Major Business
2.1.3 Lumenis Benign Prostatic Hyperplasia Devices Product and Services
2.1.4 Lumenis Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Lumenis Recent Developments/Updates
2.2 Olympus corporation
2.2.1 Olympus corporation Details
2.2.2 Olympus corporation Major Business
2.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Product and Services
2.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Olympus corporation Recent Developments/Updates
2.3 Urologix
2.3.1 Urologix Details
2.3.2 Urologix Major Business
2.3.3 Urologix Benign Prostatic Hyperplasia Devices Product and Services
2.3.4 Urologix Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Urologix Recent Developments/Updates
2.4 Boston Scientific corporation
2.4.1 Boston Scientific corporation Details
2.4.2 Boston Scientific corporation Major Business
2.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product and Services
2.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Boston Scientific corporation Recent Developments/Updates
2.5 Lisa Laser
2.5.1 Lisa Laser Details
2.5.2 Lisa Laser Major Business
2.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Product and Services
2.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Lisa Laser Recent Developments/Updates
2.6 Medifocus
2.6.1 Medifocus Details
2.6.2 Medifocus Major Business
2.6.3 Medifocus Benign Prostatic Hyperplasia Devices Product and Services
2.6.4 Medifocus Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Medifocus Recent Developments/Updates
2.7 Neotrac
2.7.1 Neotrac Details
2.7.2 Neotrac Major Business
2.7.3 Neotrac Benign Prostatic Hyperplasia Devices Product and Services
2.7.4 Neotrac Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Neotrac Recent Developments/Updates
2.8 ProArc Medical LTD
2.8.1 ProArc Medical LTD Details
2.8.2 ProArc Medical LTD Major Business
2.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product and Services
2.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 ProArc Medical LTD Recent Developments/Updates
2.9 Urotech GMBH
2.9.1 Urotech GMBH Details
2.9.2 Urotech GMBH Major Business
2.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Product and Services
2.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Urotech GMBH Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BENIGN PROSTATIC HYPERPLASIA DEVICES BY MANUFACTURER
3.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Manufacturer (2019-2024)
3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2019-2024)
3.3 Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Benign Prostatic Hyperplasia Devices by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
3.4.2 Top 6 Benign Prostatic Hyperplasia Devices Manufacturer Market Share in 2023
3.5 Benign Prostatic Hyperplasia Devices Market: Overall Company Footprint Analysis
3.5.1 Benign Prostatic Hyperplasia Devices Market: Region Footprint
3.5.2 Benign Prostatic Hyperplasia Devices Market: Company Product Type Footprint
3.5.3 Benign Prostatic Hyperplasia Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Benign Prostatic Hyperplasia Devices Market Size by Region
4.1.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
4.1.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
4.1.3 Global Benign Prostatic Hyperplasia Devices Average Price by Region (2019-2030)
4.2 North America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.3 Europe Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.4 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.5 South America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
4.6 Middle East and Africa Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
5.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2019-2030)
5.3 Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
6.2 Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2019-2030)
6.3 Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
7.2 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
7.3 North America Benign Prostatic Hyperplasia Devices Market Size by Country
7.3.1 North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
7.3.2 North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
8.2 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
8.3 Europe Benign Prostatic Hyperplasia Devices Market Size by Country
8.3.1 Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
8.3.2 Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Size by Region
9.3.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
10.2 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
10.3 South America Benign Prostatic Hyperplasia Devices Market Size by Country
10.3.1 South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
10.3.2 South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Market Size by Country
11.3.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Benign Prostatic Hyperplasia Devices Market Drivers
12.2 Benign Prostatic Hyperplasia Devices Market Restraints
12.3 Benign Prostatic Hyperplasia Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Benign Prostatic Hyperplasia Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Benign Prostatic Hyperplasia Devices
13.3 Benign Prostatic Hyperplasia Devices Production Process
13.4 Benign Prostatic Hyperplasia Devices Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Benign Prostatic Hyperplasia Devices Typical Distributors
14.3 Benign Prostatic Hyperplasia Devices Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Lumenis Basic Information, Manufacturing Base and Competitors
Table 4. Lumenis Major Business
Table 5. Lumenis Benign Prostatic Hyperplasia Devices Product and Services
Table 6. Lumenis Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Lumenis Recent Developments/Updates
Table 8. Olympus corporation Basic Information, Manufacturing Base and Competitors
Table 9. Olympus corporation Major Business
Table 10. Olympus corporation Benign Prostatic Hyperplasia Devices Product and Services
Table 11. Olympus corporation Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Olympus corporation Recent Developments/Updates
Table 13. Urologix Basic Information, Manufacturing Base and Competitors
Table 14. Urologix Major Business
Table 15. Urologix Benign Prostatic Hyperplasia Devices Product and Services
Table 16. Urologix Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Urologix Recent Developments/Updates
Table 18. Boston Scientific corporation Basic Information, Manufacturing Base and Competitors
Table 19. Boston Scientific corporation Major Business
Table 20. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product and Services
Table 21. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Boston Scientific corporation Recent Developments/Updates
Table 23. Lisa Laser Basic Information, Manufacturing Base and Competitors
Table 24. Lisa Laser Major Business
Table 25. Lisa Laser Benign Prostatic Hyperplasia Devices Product and Services
Table 26. Lisa Laser Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Lisa Laser Recent Developments/Updates
Table 28. Medifocus Basic Information, Manufacturing Base and Competitors
Table 29. Medifocus Major Business
Table 30. Medifocus Benign Prostatic Hyperplasia Devices Product and Services
Table 31. Medifocus Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Medifocus Recent Developments/Updates
Table 33. Neotrac Basic Information, Manufacturing Base and Competitors
Table 34. Neotrac Major Business
Table 35. Neotrac Benign Prostatic Hyperplasia Devices Product and Services
Table 36. Neotrac Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Neotrac Recent Developments/Updates
Table 38. ProArc Medical LTD Basic Information, Manufacturing Base and Competitors
Table 39. ProArc Medical LTD Major Business
Table 40. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product and Services
Table 41. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. ProArc Medical LTD Recent Developments/Updates
Table 43. Urotech GMBH Basic Information, Manufacturing Base and Competitors
Table 44. Urotech GMBH Major Business
Table 45. Urotech GMBH Benign Prostatic Hyperplasia Devices Product and Services
Table 46. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Urotech GMBH Recent Developments/Updates
Table 48. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Benign Prostatic Hyperplasia Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Benign Prostatic Hyperplasia Devices Production Site of Key Manufacturer
Table 53. Benign Prostatic Hyperplasia Devices Market: Company Product Type Footprint
Table 54. Benign Prostatic Hyperplasia Devices Market: Company Product Application Footprint
Table 55. Benign Prostatic Hyperplasia Devices New Market Entrants and Barriers to Market Entry
Table 56. Benign Prostatic Hyperplasia Devices Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Benign Prostatic Hyperplasia Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Benign Prostatic Hyperplasia Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Benign Prostatic Hyperplasia Devices Raw Material
Table 116. Key Manufacturers of Benign Prostatic Hyperplasia Devices Raw Materials
Table 117. Benign Prostatic Hyperplasia Devices Typical Distributors
Table 118. Benign Prostatic Hyperplasia Devices Typical Customers
Table 1. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Lumenis Basic Information, Manufacturing Base and Competitors
Table 4. Lumenis Major Business
Table 5. Lumenis Benign Prostatic Hyperplasia Devices Product and Services
Table 6. Lumenis Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Lumenis Recent Developments/Updates
Table 8. Olympus corporation Basic Information, Manufacturing Base and Competitors
Table 9. Olympus corporation Major Business
Table 10. Olympus corporation Benign Prostatic Hyperplasia Devices Product and Services
Table 11. Olympus corporation Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Olympus corporation Recent Developments/Updates
Table 13. Urologix Basic Information, Manufacturing Base and Competitors
Table 14. Urologix Major Business
Table 15. Urologix Benign Prostatic Hyperplasia Devices Product and Services
Table 16. Urologix Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Urologix Recent Developments/Updates
Table 18. Boston Scientific corporation Basic Information, Manufacturing Base and Competitors
Table 19. Boston Scientific corporation Major Business
Table 20. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product and Services
Table 21. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Boston Scientific corporation Recent Developments/Updates
Table 23. Lisa Laser Basic Information, Manufacturing Base and Competitors
Table 24. Lisa Laser Major Business
Table 25. Lisa Laser Benign Prostatic Hyperplasia Devices Product and Services
Table 26. Lisa Laser Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Lisa Laser Recent Developments/Updates
Table 28. Medifocus Basic Information, Manufacturing Base and Competitors
Table 29. Medifocus Major Business
Table 30. Medifocus Benign Prostatic Hyperplasia Devices Product and Services
Table 31. Medifocus Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Medifocus Recent Developments/Updates
Table 33. Neotrac Basic Information, Manufacturing Base and Competitors
Table 34. Neotrac Major Business
Table 35. Neotrac Benign Prostatic Hyperplasia Devices Product and Services
Table 36. Neotrac Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Neotrac Recent Developments/Updates
Table 38. ProArc Medical LTD Basic Information, Manufacturing Base and Competitors
Table 39. ProArc Medical LTD Major Business
Table 40. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product and Services
Table 41. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. ProArc Medical LTD Recent Developments/Updates
Table 43. Urotech GMBH Basic Information, Manufacturing Base and Competitors
Table 44. Urotech GMBH Major Business
Table 45. Urotech GMBH Benign Prostatic Hyperplasia Devices Product and Services
Table 46. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Urotech GMBH Recent Developments/Updates
Table 48. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Benign Prostatic Hyperplasia Devices Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Benign Prostatic Hyperplasia Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Benign Prostatic Hyperplasia Devices Production Site of Key Manufacturer
Table 53. Benign Prostatic Hyperplasia Devices Market: Company Product Type Footprint
Table 54. Benign Prostatic Hyperplasia Devices Market: Company Product Application Footprint
Table 55. Benign Prostatic Hyperplasia Devices New Market Entrants and Barriers to Market Entry
Table 56. Benign Prostatic Hyperplasia Devices Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Benign Prostatic Hyperplasia Devices Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Benign Prostatic Hyperplasia Devices Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Benign Prostatic Hyperplasia Devices Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Benign Prostatic Hyperplasia Devices Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Benign Prostatic Hyperplasia Devices Raw Material
Table 116. Key Manufacturers of Benign Prostatic Hyperplasia Devices Raw Materials
Table 117. Benign Prostatic Hyperplasia Devices Typical Distributors
Table 118. Benign Prostatic Hyperplasia Devices Typical Customers
LIST OF FIGURES
Figure 1. Benign Prostatic Hyperplasia Devices Picture
Figure 2. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Type in 2023
Figure 4. Transurethral Resection of the Prostate (TURP) Examples
Figure 5. Transurethral Microwave Therapy (TUMT) Examples
Figure 6. Transurethral Needle Ablation of the Prostate (TUNA) Examples
Figure 7. Laser Surgery Examples
Figure 8. Prostatic Stenting Examples
Figure 9. Others Examples
Figure 10. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Application in 2023
Figure 12. Hospitals and Clinics Examples
Figure 13. Ambulatory Surgical Centers(ASC) Examples
Figure 14. Home Examples
Figure 15. Others Examples
Figure 16. Global Benign Prostatic Hyperplasia Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Benign Prostatic Hyperplasia Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Benign Prostatic Hyperplasia Devices Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Benign Prostatic Hyperplasia Devices Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Benign Prostatic Hyperplasia Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Benign Prostatic Hyperplasia Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Benign Prostatic Hyperplasia Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 58. China Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Benign Prostatic Hyperplasia Devices Market Drivers
Figure 79. Benign Prostatic Hyperplasia Devices Market Restraints
Figure 80. Benign Prostatic Hyperplasia Devices Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices in 2023
Figure 83. Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
Figure 84. Benign Prostatic Hyperplasia Devices Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Benign Prostatic Hyperplasia Devices Picture
Figure 2. Global Benign Prostatic Hyperplasia Devices Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Type in 2023
Figure 4. Transurethral Resection of the Prostate (TURP) Examples
Figure 5. Transurethral Microwave Therapy (TUMT) Examples
Figure 6. Transurethral Needle Ablation of the Prostate (TUNA) Examples
Figure 7. Laser Surgery Examples
Figure 8. Prostatic Stenting Examples
Figure 9. Others Examples
Figure 10. Global Benign Prostatic Hyperplasia Devices Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 11. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Application in 2023
Figure 12. Hospitals and Clinics Examples
Figure 13. Ambulatory Surgical Centers(ASC) Examples
Figure 14. Home Examples
Figure 15. Others Examples
Figure 16. Global Benign Prostatic Hyperplasia Devices Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Benign Prostatic Hyperplasia Devices Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Benign Prostatic Hyperplasia Devices Sales Quantity (2019-2030) & (K Units)
Figure 19. Global Benign Prostatic Hyperplasia Devices Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Benign Prostatic Hyperplasia Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Benign Prostatic Hyperplasia Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Benign Prostatic Hyperplasia Devices Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Benign Prostatic Hyperplasia Devices Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Benign Prostatic Hyperplasia Devices Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 58. China Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Benign Prostatic Hyperplasia Devices Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Benign Prostatic Hyperplasia Devices Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Benign Prostatic Hyperplasia Devices Market Drivers
Figure 79. Benign Prostatic Hyperplasia Devices Market Restraints
Figure 80. Benign Prostatic Hyperplasia Devices Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia Devices in 2023
Figure 83. Manufacturing Process Analysis of Benign Prostatic Hyperplasia Devices
Figure 84. Benign Prostatic Hyperplasia Devices Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
